TREM2 and liver cancer: To evaluate the relative abundance of the TREM2+ LAM-like subtype and its clinical relevance in liver cancer patients, a signature matrix was first created from human HCC scRNA-seq data (Figure 7A) using CIBERSORTx (31), providing a reference atlas for the deconvolution of bulk RNA-seq profiles.